News | May 13, 2024
Briefs: Lupin and Aurobindo Pharma
Lupin updates on shipment of Mirabegron ER Tablets
Lupin updates on shipment of Mirabegron ER Tablets
Recommendation based on CAPItello-291 results which showed the Truqap combination reduced the risk of disease progression or death by 50%
Additional data in pregnant adults who are Virologically suppressed reinforce safety and tolerability profile of Biktarvy in broad range of people with HIV
One form of thalidomide has the intended sedative effect but the opposite mirror-image form interferes with foetal development
CHL is strengthening its play in the fast-growing beauty and personal care sector
ABRYSVO met its trial primary endpoints in adults aged 18 to 59 with an increased respiratory syncytial virus (RSV) disease risk.
Aims to become a leading global partner for botanical extracts and natural actives in the beauty and personal care market
The partners will collaborate to build a cutting-edge oligonucleotide cGMP manufacturing facility
Wacker Biotech is a CDMO for the GMP-compliant production of active ingredients for the pharmaceutical industry
The approval marks a significant milestone for the American pharmaceutical company in the field of UC
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
